Myelin injury and degraded myelin vesicles in Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

Myelin injury and degraded myelin vesicles in Alzheimer's disease.

Myelin injury and degraded myelin vesicles in Alzheimer's disease.

http://www.wikidata.org/entity/Q33791342

about

Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease Myelin basic protein associates with AβPP, Aβ1-42, and amyloid plaques in cortex of Alzheimer's disease brain Characterization of circRNA-Associated-ceRNA Networks in a Senescence-Accelerated Mouse Prone 8 Brain.Remyelination: A Potential Therapeutic Strategy for Alzheimer's Disease?Gram-negative bacterial molecules associate with Alzheimer disease pathology.Age-related white matter integrity differences in oldest-old without dementia.Inflammation Combined with Ischemia Produces Myelin Injury and Plaque-Like Aggregates of Myelin, Amyloid-β and AβPP in Adult Rat Brain.Cellular Pharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan on Brain Cells.Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.Characterization of Cerebral Damage in a Monkey Model of Alzheimer's Disease Induced by Intracerebroventricular Injection of Streptozotocin.Effects of Chronic Scopolamine Treatment on Cognitive Impairments and Myelin Basic Protein Expression in the Mouse Hippocampus.Alzheimer's Disease Mutant Mice Exhibit Reduced Brain Tissue Stiffness Compared to Wild-type Mice in both Normoxia and following Intermittent Hypoxia Mimicking Sleep Apnea.Lipopolysaccharide Associates with Amyloid Plaques, Neurons and Oligodendrocytes in Alzheimer's Disease Brain: A Review.Association between Alzheimer's disease pathogenesis and early demyelination and oligodendrocyte dysfunction.Human and Microbial Proteins From Corpora Amylacea of Alzheimer's Disease.Competing Endogenous RNA Regulations in Neurodegenerative Disorders: Current Challenges and Emerging Insights

P2860

Q26770754-82D60BD3-59B5-44F3-9EC5-3EA8180E109A Q28087176-7C1A8EAD-AA1F-4431-B769-59CA401E08DF Q35576628-79821A81-2B65-4B4F-BC99-98C6D904CC27 Q38663797-AE671F1D-150A-441F-BB3B-0EF505D2948A Q38814687-3447318B-DBE0-4677-BCBF-CFACDFDDFC7D Q39246230-B011D147-748E-4B3B-A915-3904ADE7805A Q40192901-C02D6574-13C1-427A-BEDE-8887B42129CA Q42144566-51EECDCB-CBD4-4B4B-8A4E-39C3B94FCA70 Q42363344-685FA907-809C-4388-A6F7-290DCCC39870 Q47417382-1EA1D3AC-6D5D-4850-9A9F-F0933478CDBD Q48226352-AA9738D7-BBFC-40AE-829C-C4DDD2F2C7B5 Q48656776-DCCB60FC-678D-42F4-9FB9-1374557DC4E8 Q49524953-8AF05438-E62C-4870-A8D3-A1EDA5FF33C5 Q51764702-E0E76993-E7A9-482A-AFC7-6553FC05AA45 Q55415412-CB0F5AA0-56E5-437A-B9BC-CD722373D624 Q55509961-B68D093F-E517-450E-ADC2-2B9D61DB2F43 Q57817968-F8688E16-9BF7-4D0E-84E0-4CE8252E9175

P2860

Myelin injury and degraded myelin vesicles in Alzheimer's disease.

http://www.wikidata.org/entity/Q33791342

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Myelin injury and degraded myelin vesicles in Alzheimer's disease.

@ast

Myelin injury and degraded myelin vesicles in Alzheimer's disease.

@en

type

label

Myelin injury and degraded myelin vesicles in Alzheimer's disease.

@ast

Myelin injury and degraded myelin vesicles in Alzheimer's disease.

@en

prefLabel

Myelin injury and degraded myelin vesicles in Alzheimer's disease.

@ast

Myelin injury and degraded myelin vesicles in Alzheimer's disease.

@en

P1433

Q33791342-528D8721-FC2F-468D-B6B7-B9E19E2D20C3

P1476

Q33791342-F7C29ACF-D948-40CB-970B-A21BB3A7D4DE

P2093

Q33791342-385D541A-54B0-4605-9E0F-9702EDC3D398

Q33791342-50F6A6B3-CBE9-4C2B-9B58-E7EAC540E003

Q33791342-9821F044-4540-4D76-A426-1FD3DE9851E1

Q33791342-C30BDA21-0592-4DB8-924A-3DBD0011AD1D

Q33791342-D66FE0BF-E1BB-4150-B9B4-2991A441EED0

Q33791342-E17718D0-E09E-4556-9CAF-B03909C746E3

Q33791342-E97EB2FE-3555-491D-91EB-9FE843D9AA71

Q33791342-ED059D8A-219F-4B06-BAE9-A1673F1035A5

P2860

Q33791342-07F110F7-CBAC-4044-99B2-A4255C878871

Q33791342-20CF3266-0C55-4FD2-9D96-F9B4D30AC3AD

Q33791342-231A129C-FF14-407F-9C3E-3F10C93B48E9

Q33791342-2CF86B69-8F01-402A-B577-BB7E57A704CD

Q33791342-2DAADA22-0CFF-451E-835B-5D6158F60F25

Q33791342-332219C6-C12E-4930-945D-B28E82252CED

Q33791342-344A0365-BF24-4AF5-8202-6B889B070BEA

Q33791342-41CAA34E-98F0-4A2B-90E0-7ADF81FE8CCA

Q33791342-43F04B7E-4EFD-43DA-A13D-572DF97EB7F6

Q33791342-643BE232-782A-4B2C-87D7-7625F682AA25

P304

Q33791342-585BF593-2A57-40CD-B3DE-EC28170EBBA4

P31

Q33791342-D8D2442A-EAB9-47C5-816F-720C25793296

P356

Q33791342-1B449E2C-0A22-436C-8874-A1EF404FABA0

P433

Q33791342-A3812D64-1C1D-4EC8-95E6-0CCDE505D356

P478

Q33791342-1C310CFC-1CB0-4876-B27F-F099FB1323A2

P50

Q33791342-51DBF305-01B0-4960-9C2A-5DEC7B8F141F

P577

Q33791342-3B349059-0CFD-4798-8A47-583C68D41451

P698

Q33791342-F3761967-A01E-44A1-9B2D-96EC2A939CAC

P921

Q33791342-31ED38F8-E9A3-4762-AE1D-9A9B400E06C3

P932

Q33791342-F0305017-81D4-4128-A80E-B40B4B35091C

P356

1567205011666140131120922

P1433

Current Alzheimer Research

P1476

Myelin injury and degraded myelin vesicles in Alzheimer's disease.

@en

P2093

Boryana Stamova

http://www.w3.org/2001/XMLSchema#string

Bradley P Ander

http://www.w3.org/2001/XMLSchema#string

Christopher Cox

http://www.w3.org/2001/XMLSchema#string

Dazhi Liu

http://www.w3.org/2001/XMLSchema#string

Frank R Sharp

http://www.w3.org/2001/XMLSchema#string

Glen C Jickling

http://www.w3.org/2001/XMLSchema#string

Lee-Way Jin

http://www.w3.org/2001/XMLSchema#string

Xinhua Zhan

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders

The case described by Alois Alzheimer in 1911. Historical and conceptual perspectives based on the clinical record and neurohistological sections.

Ascending central canal dilation and progressive ependymal disruption in a contusion model of rodent chronic spinal cord injury

Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies

Cerebral microvascular pathology in aging and Alzheimer's disease.

Matrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairment

Alterations of the sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment targets?

Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease.

P304

232-238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1567205011666140131120922

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Charles DeCarli

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24484278

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4066812

http://www.w3.org/2001/XMLSchema#string